Student & Trainee (ST)

PT-002 - DETERMINING CRITICAL PHYSIOLOGICAL AND DRUG SPECIFIC PARAMETERS FOR ENHANCING A PHYSIOLOGICALLY-BASED PHARMACOKINETICS MODEL FOR THE FEMALE REPRODUCTIVE TRACT

PT-024 - EVALUATION OF PRESCRIBER BEHAVIOR IN RESPONSE TO CYP2C19-CLOPIDOGREL BEST PRACTICE ALERTS.

PT-026 - EXPLORING THE RELATIONSHIP BETWEEN ANTIDEPRESSANT TREATMENT, NEUROCHEMICALS IN THE BRAIN AND ANXIETY/DEPRESSION SYMPTOMS IN YOUTH

PT-027 - UTILIZING ADAPTIVE DOSING SIMULATIONS AND MACHINE LEARNING TO IMPROVE PREDICTION AND MANAGEMENT OF NEUTROPENIA RATES.

PI-118 - DRUG-INDUCED ADE PREDICTION MODEL PERFORMANCE DEPENDS ON STATISTICAL MODELS AND STATISTICALLY SIGNIFICANT THRESHOLDS FOR DRUG-INDUCED ADE DATA

PI-120 - LEVERAGING MACHINE LEARNING FOR HIGH-DIMENSIONAL COVARIATE SCREENING IN ALZHEIMER'S DISEASE PROGRESSION MODELING.

PI-121 - OPTIMIZING THE FIRST-IN-HUMAN STUDY DESIGN FOR BIOLOGICS EXHIBITING TARGET-MEDIATED DRUG DISPOSITION

PI-122 - WHAT CAN WE LEARN FROM TRENDS IN PATIENT RECRUITMENT ADVERTISING IN THE PAST 20 YEARS?

PII-115 - A SIMPLE AND SENSITIVE ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (UHPLC-MS/MS) ASSAY TO QUANTIFY TIZANIDINE AND ITS METABOLITES IN HUMAN PLASMA

PII-116 - DEVELOPMENT OF CHARACTERIZATION OF A TRANSDERMAL DRUG DELIVERY SYSTEM FOR ALZHEIMER'S DRUGS.

PII-117 - DRUG DEVELOPMENT CONSIDERATIONS FOR DRUG-DRUG INTERACTION STUDIES WITH FLUCONAZOLE AS A SIMULTANEOUS INHIBITOR OF MULTIPLE METABOLIC ENZYMES.

PII-118 - EFAVIRENZ ALTERS THE DISPOSITION AND PHARMACODYNAMICS OF TIZANIDINE IN HEALTHY VOLUNTEERS

PII-119 - EVALUATING AND OPTIMIZING ALLOMETRIC SCALING APPROACHES FOR PREDICTING PEDIATRIC EXPOSURES OF INTRAVENOUSLY ADMINISTERED SMALL MOLECULES AND BIOLOGICS FROM ADULT DATA

PII-121 - PHARMACOKINETICS AND SAFETY OF NANOPARTICLE FENOFIBRATE (AD-104-A) IN RENAL IMPAIRMENT PATIENTS.